New treatment cuts Covid deaths by 24%

SHARE:

Patients across the UK who are admitted to intensive care units due to COVID-19 are set to receive new life-saving treatments which can reduce the time spent in hospital by up to 10 days, the government has announced today (Thursday 7 January).

Results from the government-funded REMAP-CAP clinical trial published today showed tocilizumab and sarilumab reduced the relative risk of death by 24%, when administered to patients within 24 hours of entering intensive care.

Most of the data came from when the drugs were administered in addition to a corticosteroid, such as dexamethasone – also discovered through government-backed research through the RECOVERY clinical trial – which is already provided as standard of care to the NHS.

Patients receiving these drugs, typically used to treat rheumatoid arthritis, left intensive care between 7 to 10 days earlier on average. The rollout of these treatments could therefore contribute significantly towards reducing pressures on hospitals over the coming weeks and months.

Updated guidance will be issued tomorrow by the government and the NHS to trusts across the UK, encouraging them to use tocilizumab in their treatment of COVID-19 patients who are admitted to intensive care units, effective immediately.

Supplies of tocilizumab are already available in hospitals across the UK and clinicians will be able to treat all those admitted to intensive care units, potentially saving hundreds of lives. The department is working closely with Roche, who manufacture tocilizumab, to ensure treatments continue to be available to UK patients.

Health and Social Care Secretary Matt Hancock said: "The UK has proven time and time again it is at the very forefront of identifying and providing the most promising, innovative treatments for its patients.

"Today’s results are yet another landmark development in finding a way out of this pandemic and, when added to the armoury of vaccines and treatments already being rolled out, will play a significant role in defeating this virus.

"We have worked quickly to ensure this treatment is available to NHS patients without delay, meaning hundreds of lives will be saved.

"I am hugely proud of the significant role our NHS and its patients have played in this international trial, and grateful to the outstanding scientists and clinicians behind REMAP-CAP who have brought this treatment to our patients." 

Deputy Chief Medical Officer Professor Jonathan Van-Tam said: "This is a significant step forward for increasing survival of patients in intensive care with COVID-19. The data shows that tocilizumab, and likely sarilumab, speed up and improve the odds of recovery in intensive care, which is crucial for helping to relieve pressure on intensive care and hospitals and saving lives.

"This is evidence of the UK’s excellent research infrastructure and life sciences industry advancing global understanding of this disease, which we have done both through our own programme of clinical research and through our ability to make very large contributions to international studies."

In June last year, the UK government approved dexamethasone as the world’s first treatment proven to reduce mortality for COVID-19. The REMAP-CAP trial found that the rate of death for those in intensive care units on corticosteroids, such as dexamethasone, and respiratory support alone was 35%, which was reduced to 28% when tocilizumab was also administered.

Professor Stephen Powis, NHS national medical director, said: "The fact there is now another drug that can help to reduce mortality for patients with COVID-19 is hugely welcome news and another positive development in the continued fight against the virus.

"This signals how the NHS is working all the time to find new treatments and therapies, but the best advice for individuals is to remember the hands, face, space guidance." 

$show=post

$show=404

404 / ERROR \ 404

THAT PAGE CANNOT BE FOUND

$show=404

[/fa-rss/ LATEST]_$type=three$author=hide$cm=0$ct=0$va=0$hide=home

[/fa-arrow-alt-circle-down/ READ ALL ABOUT IT:]_$type=one$m=0$c=1$cm=0$l=0$va=0$hide=home$sr=random

$type=three$m=0$l=0$c=6$cm=0$hide=home$source=random

Name

Book,1,Cleator Moor History,48,Cleator Moor News,150,Copeland Borough Council,111,Cumbria News,2082,Featured,299,News,3113,Photography,24,Photos For Sale,10,Photos Of Cleator Moor,10,Photos of Cumbria,14,UK News,360,Walking Routes,3,West Cumbria News,536,Your MP,71,
ltr
item
Cleator Moor | Cumbria: Little Ireland: New treatment cuts Covid deaths by 24%
New treatment cuts Covid deaths by 24%
https://lh3.googleusercontent.com/-9Z6b7MwF6fQ/X_c5cGBtbpI/AAAAAAAAeEs/nnbVNRFkGWoOS-DjyU3Ds-U36wSp-j2TwCLcBGAsYHQ/s1600/1610037615230865-0.png
https://lh3.googleusercontent.com/-9Z6b7MwF6fQ/X_c5cGBtbpI/AAAAAAAAeEs/nnbVNRFkGWoOS-DjyU3Ds-U36wSp-j2TwCLcBGAsYHQ/s72-c/1610037615230865-0.png
Cleator Moor | Cumbria: Little Ireland
https://www.littleireland.co.uk/2021/01/new-treatment-cuts-covid-deaths-by-24.html
https://www.littleireland.co.uk/
https://www.littleireland.co.uk/
https://www.littleireland.co.uk/2021/01/new-treatment-cuts-covid-deaths-by-24.html
true
4367044361856627147
UTF-8
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All SUGGESTED READING LITTLE IRELAND ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share to a social network STEP 2: Click the link on your social network Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy Table of Content